This study is the first study demonstrating the effect of CTGF/BAMBI axis on regulation of MM cell proliferation and thus adds to a growing body of literature identifying BAMBI as a potential treatment target for cancer therapy [31, 32]. The gene discussed is CCN2; the disease is Miyoshi myopathy.